These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 21193734)

  • 1. Diabetic retinopathy: targeting vasoregression.
    Hammes HP; Feng Y; Pfister F; Brownlee M
    Diabetes; 2011 Jan; 60(1):9-16. PubMed ID: 21193734
    [No Abstract]   [Full Text] [Related]  

  • 2. [Angiogenesis and diabetic retinopathy: specific connections to neuroretinal tissue].
    Paques M; Massin P; Bonnel S; Sahel JA
    Journ Annu Diabetol Hotel Dieu; 2005; ():33-7. PubMed ID: 16161303
    [No Abstract]   [Full Text] [Related]  

  • 3. Connection of pericyte-angiopoietin-Tie-2 system in diabetic retinopathy: friend or foe?
    Cai J; Ruan Q; Chen ZJ; Han S
    Future Med Chem; 2012 Nov; 4(17):2163-76. PubMed ID: 23190105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Erythropoietin as a retinal angiogenic factor in proliferative diabetic retinopathy].
    Watanabe D
    Nippon Ganka Gakkai Zasshi; 2007 Nov; 111(11):892-8. PubMed ID: 18051819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel role of erythropoietin in proliferative diabetic retinopathy.
    Takagi H; Watanabe D; Suzuma K; Kurimoto M; Suzuma I; Ohashi H; Ojima T; Murakami T
    Diabetes Res Clin Pract; 2007 Sep; 77 Suppl 1():S62-4. PubMed ID: 17481772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retinal overexpression of angiopoietin-2 mimics diabetic retinopathy and enhances vascular damages in hyperglycemia.
    Pfister F; Wang Y; Schreiter K; vom Hagen F; Altvater K; Hoffmann S; Deutsch U; Hammes HP; Feng Y
    Acta Diabetol; 2010 Mar; 47(1):59-64. PubMed ID: 19238311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential regulation of blood flow-induced neovascularization and mural cell recruitment by vascular endothelial growth factor and angiopoietin signalling.
    Stone OA; Carter JG; Lin PC; Paleolog E; Machado MJ; Bates DO
    J Physiol; 2017 Mar; 595(5):1575-1591. PubMed ID: 27868196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting Tie2 for Treatment of Diabetic Retinopathy and Diabetic Macular Edema.
    Campochiaro PA; Peters KG
    Curr Diab Rep; 2016 Dec; 16(12):126. PubMed ID: 27778249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Aging and retinal vascular diseases].
    Takagi H
    Nippon Ganka Gakkai Zasshi; 2007 Mar; 111(3):207-30; discussion 231. PubMed ID: 17402563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retinopathy in the pregnant diabetic.
    Sinclair SH; Nesler CL; Schwartz SS
    Clin Obstet Gynecol; 1985 Sep; 28(3):536-52. PubMed ID: 2414048
    [No Abstract]   [Full Text] [Related]  

  • 11. Vascular endothelial growth factor and angiopoietin are required for prostate regeneration.
    Wang GM; Kovalenko B; Huang Y; Moscatelli D
    Prostate; 2007 Apr; 67(5):485-99. PubMed ID: 17221843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Vascular stabilization by angiopoietin-1.].
    Fukuhara S; Mochizuki N
    Nihon Yakurigaku Zasshi; 2010 Jul; 136(1):26-30. PubMed ID: 20628210
    [No Abstract]   [Full Text] [Related]  

  • 13. Angiopoietin modulation of vascular endothelial growth factor: Effects on retinal endothelial cell permeability.
    Peters S; Cree IA; Alexander R; Turowski P; Ockrim Z; Patel J; Boyd SR; Joussen AM; Ziemssen F; Hykin PG; Moss SE
    Cytokine; 2007 Nov; 40(2):144-50. PubMed ID: 17959386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythropoietin as a retinal angiogenic factor in proliferative diabetic retinopathy.
    Watanabe D; Suzuma K; Matsui S; Kurimoto M; Kiryu J; Kita M; Suzuma I; Ohashi H; Ojima T; Murakami T; Kobayashi T; Masuda S; Nagao M; Yoshimura N; Takagi H
    N Engl J Med; 2005 Aug; 353(8):782-92. PubMed ID: 16120858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Vascular endothelial cells and adjoining cells for their mutual adhesion/interaction for stabilization and angiogenesis].
    Fukuhara S; Mochizuki N
    Seikagaku; 2010 Apr; 82(4):290-301. PubMed ID: 20496747
    [No Abstract]   [Full Text] [Related]  

  • 16. Angiogenic pathways in diabetic retinopathy.
    Aiello LP
    N Engl J Med; 2005 Aug; 353(8):839-41. PubMed ID: 16120866
    [No Abstract]   [Full Text] [Related]  

  • 17. Critical role of angiopoietins/Tie-2 in hyperglycemic exacerbation of myocardial infarction and impaired angiogenesis.
    Tuo QH; Zeng H; Stinnett A; Yu H; Aschner JL; Liao DF; Chen JX
    Am J Physiol Heart Circ Physiol; 2008 Jun; 294(6):H2547-57. PubMed ID: 18408125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of proliferative diabetic retinopathy.
    Gündüz K; Bakri SJ
    Compr Ophthalmol Update; 2007; 8(5):245-56. PubMed ID: 18201511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelial progenitor cells (EPCs) mobilized and activated by neurotrophic factors may contribute to pathologic neovascularization in diabetic retinopathy.
    Liu X; Li Y; Liu Y; Luo Y; Wang D; Annex BH; Goldschmidt-Clermont PJ
    Am J Pathol; 2010 Jan; 176(1):504-15. PubMed ID: 19948824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activated monocytes and granulocytes, capillary nonperfusion, and neovascularization in diabetic retinopathy.
    Schröder S; Palinski W; Schmid-Schönbein GW
    Am J Pathol; 1991 Jul; 139(1):81-100. PubMed ID: 1713023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.